Nonalcoholic fatty liver disease (NAFLD) is linked to coronary artery calcification and carotid intima-media thickness (IMT) in people without a history of cardiovascular disease, a recent study has shown.
Statins, depending on types and doses, appear to be associated with an increased risk of developing transaminitis or hypertransaminasemia, with the results of a meta-analysis showing that high-dose atorvastatin, rosuvastatin and lovastatin yield higher risks of liver-function test abnormalities.
Use of aspirin on a daily basis appears to be associated with less severe histologic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis, as well as reduce the risk of progression to advanced fibrosis with time, a study has found.
Liver Update is a series of international scientific meetings organized by the Malaysian Liver Foundation. It is meant to keep our healthcare professionals (HCPs) updated on current developments and new advances in the management of liver diseases. Usually held around mid to late July, the conference is a must-go for hepatologists, GPs and allied health professionals alike.